topic0
Tumour NOS [neop] 0.00476512570286
HCV [virs] 0.00309670298762
Compared [acty] 0.00332000834169
Radiofrequency Ablation [topp] 0.00289916801778
Transcatheter [spco] 0.00351746779896
Based [ftcn] 0.00287509839276
Survival [acty] 0.00681425083924
Group [idcn] 0.0028620491832
resection [topp] 0.00404664224383
Including [ftcn] 0.00360815731331
HEPATITIS C VIRUS [virs] 0.00537717213967
chemoembolisation [topp] 0.00439906213203
HEPATITIS B VIRUS [virs] 0.00367931650311
SERUM [bdsu] 0.00330122441435
Independent [idcn] 0.00622560180487
Study [mnob] 0.00926988798642
included [ftcn] 0.00272875707385
DIAGNOSIS [fndg] 0.00479134501715
Conclusions [idcn] 0.00297249966954
Methods [inpr] 0.00828007666957
CANCER [neop] 0.00400988222542
Cases [ftcn] 0.00283348163753
Intrahepatic Cholangiocarcinoma [neop] 0.00629645622443
Arterial [bpoc] 0.00397238780703
YEARS [tmco] 0.00615529133065
Criteria [inpr] 0.00313962555042
therapy [ftcn] 0.00368925066109
Liver Transplantation [topp] 0.00509128850815
YEAR [tmco] 0.0065398032386
LIVER [bpoc] 0.00572686680425
LIVER CIRRHOSIS [dsyn] 0.00289746949895
Related [qlco] 0.00649507721047
Identified [qlco] 0.00357828024351
treatment [ftcn] 0.00532170116211
CIRRHOSIS [dsyn] 0.00427117848623
Increased [qnco] 0.00293126234529
Levels [qlco] 0.0043436253419
Risk Factors [qnco] 0.010552792737
Pathology [bmod] 0.00309863759161
Curative [cnce] 0.00294743871991
topic1
Tumour NOS [neop] 0.00727354373717
Important [qlco] 0.00259257115486
Treated [ftcn] 0.00281814102566
Cases [ftcn] 0.00313552911675
Present [qnco] 0.00309949771238
Survival [acty] 0.00599182356496
Group [idcn] 0.00242957930645
Including [ftcn] 0.0029404983942
Hazard Ratio [qnco] 0.00253040377833
SMALL [qnco] 0.00297242399647
experience [menp] 0.00240455514069
lesions [fndg] 0.00258106757444
Methods [inpr] 0.00440857464493
Screening [hlca] 0.00403749465549
Hepatectomy [topp] 0.0026978875062
Performed [ftcn] 0.003144150919
HEPATITIS B VIRUS [virs] 0.00260330063677
SERUM [bdsu] 0.00289487054056
Independent [idcn] 0.00319825920004
LOCAL [spco] 0.00241363094744
Study [mnob] 0.00932808583238
Mortality [qnco] 0.00588518267999
Conclusions [idcn] 0.00306939357751
FIBROSIS [patf] 0.00357878206142
Median [spco] 0.00406879463081
YEARS [tmco] 0.00711187649331
Higher [qlco] 0.00293908940152
Post [tmco] 0.00232429058679
Liver Transplantation [topp] 0.00655847142812
YEAR [tmco] 0.00325013269347
LIVER [bpoc] 0.00499623428835
Related [qlco] 0.00293650555519
Range [qnco] 0.00284016429644
Identified [qlco] 0.00325149644734
treatment [ftcn] 0.00314737630868
CIRRHOSIS [dsyn] 0.00656322087194
Transplantation [topp] 0.00354335061871
Risk Factors [qnco] 0.0106258736385
Pathology [bmod] 0.00269276683231
Increased [qnco] 0.00358972786656
topic2
Tumour NOS [neop] 0.00536648863438
Median [spco] 0.00319151136476
absence [ftcn] 0.00239948763328
Groups [idcn] 0.00300812020941
Survival [acty] 0.00871439011747
Group [idcn] 0.00391613361852
resection [topp] 0.00797997703373
CHOLANGITIS, PRIMARY SCLEROSING [dsyn] 0.00318121855911
CI [geoa] 0.00281416423392
HEPATITIS C VIRUS [virs] 0.00295482014536
Hazard Ratio [qnco] 0.00262750970908
Hepatic [blor] 0.00242469391891
LIVER [bpoc] 0.00765556181225
Performed [ftcn] 0.00419926746045
HEPATITIS B VIRUS [virs] 0.00447292071707
Independent [idcn] 0.00343344697145
Study [mnob] 0.00924132691152
included [ftcn] 0.00336980440107
DIAGNOSIS [fndg] 0.00531902722525
Conclusions [idcn] 0.00358618903453
Pathology [bmod] 0.00244410532032
Methods [inpr] 0.00649300046902
Risk Factors [qnco] 0.0128504119754
Cases [ftcn] 0.00713795848734
YEARS [tmco] 0.00613350312048
Higher [qlco] 0.00309783050059
Mortality [qnco] 0.00329023351846
therapy [ftcn] 0.00244398321768
YEAR [tmco] 0.00289364935383
Hepatectomy [topp] 0.0041085069797
LIVER CIRRHOSIS [dsyn] 0.00252073294103
Related [qlco] 0.00449312476035
Postoperative [tmco] 0.00339180076972
treatment [ftcn] 0.00759172825818
CIRRHOSIS [dsyn] 0.00873359718159
Levels [qlco] 0.0025243282792
Compared [acty] 0.00570164945255
Association [menp] 0.0028366447212
Increased [qnco] 0.00323709196212
Transarterial Chemoembolization [topp] 0.0037064731707
topic3
Tumour NOS [neop] 0.00473392360571
Suggest [idcn] 0.00246992902531
Radiofrequency Ablation [topp] 0.0033329403146
absence [ftcn] 0.00299819404779
Parameters [fndg] 0.00235339460889
Including [ftcn] 0.00287686582901
Survival [acty] 0.00372797458344
Group [idcn] 0.00436617048306
Based [ftcn] 0.00500486054156
CI [geoa] 0.00241002011952
Hepatic [blor] 0.00271553822257
Screening [hlca] 0.00271477437982
Performed [ftcn] 0.00285307858995
Independent [idcn] 0.00332110415295
Invasion [fndg] 0.00447334792877
Study [mnob] 0.00608410333458
Mortality [qnco] 0.00330720198391
Evaluate [hlca] 0.00266281615696
Conclusions [idcn] 0.00384105458804
Exposure NOS [inpo] 0.00255456283403
Methods [inpr] 0.00475778794312
CANCER [neop] 0.00399992236068
Cases [ftcn] 0.006238045361
Marker [clna] 0.00311400176592
YEARS [tmco] 0.00569810763274
Liver Transplantation [topp] 0.00587617853245
YEAR [tmco] 0.00406869914676
LIVER [bpoc] 0.00653943984908
Related [qlco] 0.0032203204417
Focal Nodular Hyperplasia [dsyn] 0.00325654630742
Identified [qlco] 0.00289159042733
Progression [patf] 0.00259953254673
treatment [ftcn] 0.00321859384058
CIRRHOSIS [dsyn] 0.00331689417445
Preoperative [tmco] 0.00245639775959
Levels [qlco] 0.00389346979712
Risk Factors [qnco] 0.00368661307872
Pathology [bmod] 0.0037959018384
Increased [qnco] 0.00296247229677
Induced [ftcn] 0.0042953778721
topic4
Tumour NOS [neop] 0.00626998013345
ABLATION [topp] 0.00278784352197
Radiofrequency Ablation [topp] 0.00526363744584
Higher [qlco] 0.00303868344251
Groups [idcn] 0.00349961368134
Survival [acty] 0.00381234361375
Group [idcn] 0.00818831225776
Risk Factors [qnco] 0.00557479195271
Based [ftcn] 0.00355339033659
HEPATITIS C VIRUS [virs] 0.0053471210866
Hepatic [blor] 0.00350692465858
Performed [ftcn] 0.00349950617803
HEPATITIS B VIRUS [virs] 0.00292432544364
Observed [ftcn] 0.00329060518565
SERUM [bdsu] 0.0036049180193
Independent [idcn] 0.00290579875505
Invasion [fndg] 0.00448056638084
LOCAL [spco] 0.00449553190954
Study [mnob] 0.00689824326683
Mortality [qnco] 0.00345000610006
Conclusions [idcn] 0.00326064609121
Methods [inpr] 0.0060528591354
CANCER [neop] 0.00442460110903
Cases [ftcn] 0.00370360765562
Including [ftcn] 0.00284187516987
Treated [ftcn] 0.00375389297153
YEARS [tmco] 0.00725237021701
LOWER [spco] 0.00297066794533
Cholangiocarcinoma [neop] 0.00358114042411
Liver Transplantation [topp] 0.00483467792234
LIVER [bpoc] 0.00877002494536
Related [qlco] 0.00433425368514
Surgery [bmod] 0.00265044075828
treatment [ftcn] 0.0100413731691
CIRRHOSIS [dsyn] 0.00719421736898
Levels [qlco] 0.0036698536139
Compared [acty] 0.00602059944096
Pathology [bmod] 0.00368322996674
Increased [qnco] 0.0042630730432
HCC [neop] 0.00526256537784
topic5
Tumour NOS [neop] 0.00372780326351
HCV [virs] 0.0043060271027
Higher [qlco] 0.00324891305099
Present [qnco] 0.00272799667557
Including [ftcn] 0.00257091079979
Survival [acty] 0.00280133775821
Group [idcn] 0.00273335946561
Based [ftcn] 0.00260148960023
CI [geoa] 0.00326938179908
HEPATITIS C VIRUS [virs] 0.00564248089155
Hepatic [blor] 0.00390368713521
Subject [grup] 0.00280976293103
Mice [mamm] 0.00331967125711
HEPATITIS B VIRUS [virs] 0.00343990907887
Suggest [idcn] 0.00263206565678
Study [mnob] 0.00775115184063
Mortality [qnco] 0.00399103892693
Conclusions [idcn] 0.00370300496236
Nonalcoholic Fatty Liver Disease [dsyn] 0.00396818288916
FIBROSIS [patf] 0.00358679789036
Infected [fndg] 0.00250142970478
Risk Factors [qnco] 0.00717913893453
Cases [ftcn] 0.00577593023549
ALT [neop] 0.0031787612776
YEARS [tmco] 0.00463418288684
Human [humn] 0.00410168920902
Association [menp] 0.00300550571012
YEAR [tmco] 0.00286748455803
LIVER [bpoc] 0.00956226783962
Steatohepatitis [dsyn] 0.00262249156234
Related [qlco] 0.00451474218592
control [qlco] 0.00301162923085
treatment [ftcn] 0.00383029573273
CIRRHOSIS [dsyn] 0.0035255210377
Methods [inpr] 0.00390345432128
Levels [qlco] 0.00623797011112
Compared [acty] 0.00363382913275
Pathology [bmod] 0.00307431745206
CANCER [neop] 0.00293982957365
Increased [qnco] 0.00327108672823
topic6
Tumour NOS [neop] 0.00358673618302
Size [spco] 0.00257881786618
Groups [idcn] 0.00269260651293
Survival [acty] 0.0134746689699
Group [idcn] 0.00484775444901
resection [topp] 0.00859878141599
CI [geoa] 0.004096309193
HIV [virs] 0.00299490990125
Hazard Ratio [qnco] 0.00292008318764
Intrahepatic [spco] 0.00443402037824
Nonalcoholic Steatohepatitis [dsyn] 0.00475954365287
Hepatic [blor] 0.0033371411797
Subject [grup] 0.00315489493509
Performed [ftcn] 0.00284627495615
HEPATITIS B VIRUS [virs] 0.00337230490264
Observed [ftcn] 0.00273715505625
SERUM [bdsu] 0.00302065499227
Independent [idcn] 0.00380691051314
Study [mnob] 0.0103082147459
Mortality [qnco] 0.00353193626119
Conclusions [idcn] 0.00431027759652
Methods [inpr] 0.00523158089541
Infected [fndg] 0.00273146386078
CANCER [neop] 0.00257969297402
Cases [ftcn] 0.00605112420596
Intrahepatic Cholangiocarcinoma [neop] 0.00419283920202
YEARS [tmco] 0.00553553517256
control [qlco] 0.00288623290293
Cholangiocarcinoma [neop] 0.00544336655413
Liver Transplantation [topp] 0.00685671019646
YEAR [tmco] 0.00902111742187
LIVER [bpoc] 0.00537753282131
Related [qlco] 0.00431816187915
Genotype [orga] 0.00302422556274
Identified [qlco] 0.00383138251699
Odds Ratio [qnco] 0.00269428714443
treatment [ftcn] 0.00338932937262
CIRRHOSIS [dsyn] 0.00836044217361
Risk Factors [qnco] 0.0066194025414
Increased [qnco] 0.00513795813768
topic7
Tumour NOS [neop] 0.00340958029649
ABLATION [topp] 0.00258402465306
Important [qlco] 0.00285304625709
Radiofrequency Ablation [topp] 0.0047596301998
Present [qnco] 0.00279669729962
Based [ftcn] 0.00221789728926
Survival [acty] 0.00741247082741
Group [idcn] 0.00286356403458
resection [topp] 0.00534302421807
Including [ftcn] 0.00316634704015
SEVERE [qlco] 0.0022920769668
HEPATITIS C VIRUS [virs] 0.00310682491954
Hepatic [blor] 0.00439839092201
Hepatectomy [topp] 0.00639545626024
OBESITY [dsyn] 0.00247061834537
Independent [idcn] 0.00312342751631
Invasion [fndg] 0.00239341855108
Study [mnob] 0.00737459138077
Mortality [qnco] 0.00225859016821
DIAGNOSIS [fndg] 0.00251198283695
Conclusions [idcn] 0.00327402639965
SCORE [qnco] 0.00225787420301
Nonalcoholic Fatty Liver Disease [dsyn] 0.00330901963096
Methods [inpr] 0.00350254523475
Enhancement [topp] 0.00253414281455
Cases [ftcn] 0.0117742779891
YEARS [tmco] 0.00240927953553
CANCER [neop] 0.0024470508842
YEAR [tmco] 0.00467437182462
LIVER [bpoc] 0.00752056554289
Odds Ratio [qnco] 0.00258816366304
treatment [ftcn] 0.00337991864446
CIRRHOSIS [dsyn] 0.00308104165301
FIBROSIS [patf] 0.00636020607049
Risk Factors [qnco] 0.00661275972271
Pathology [bmod] 0.00318727370264
Tumors [neop] 0.00257215162312
Increased [qnco] 0.00295457144832
HCC [neop] 0.00514103875786
Evaluated [hlca] 0.00225348384985
topic8
Tumour NOS [neop] 0.00376179688226
Radiofrequency Ablation [topp] 0.0111341281138
Transcatheter [spco] 0.00327992062238
Groups [idcn] 0.00354778532997
Survival [acty] 0.00632217175819
Group [idcn] 0.00443515489993
resection [topp] 0.00489896636083
Including [ftcn] 0.00362587136101
SMALL [qnco] 0.00249148070066
Nonalcoholic Steatohepatitis [dsyn] 0.00244646968605
Performed [ftcn] 0.00377581250465
HEPATITIS B VIRUS [virs] 0.00423790816921
Independent [idcn] 0.00259005566153
Study [mnob] 0.0071876118631
included [ftcn] 0.00369477462565
DIAGNOSIS [fndg] 0.00238817634801
Conclusions [idcn] 0.0035944978161
Nonalcoholic Fatty Liver Disease [dsyn] 0.00477710748495
Methods [inpr] 0.00531941456337
Risk Factors [qnco] 0.00730744655897
Cases [ftcn] 0.00410709646691
Intrahepatic Cholangiocarcinoma [neop] 0.00291036517878
Arterial [bpoc] 0.00288068096938
Treated [ftcn] 0.00265191877233
YEARS [tmco] 0.00557603790346
control [qlco] 0.00355075259613
CANCER [neop] 0.00251000779529
LOWER [spco] 0.00247313629753
YEAR [tmco] 0.00331932305749
LIVER [bpoc] 0.0029366220076
Related [qlco] 0.00676197582853
Genotype [orga] 0.00307736424515
Identified [qlco] 0.0033065925954
treatment [ftcn] 0.00639889795596
CIRRHOSIS [dsyn] 0.00466412940337
Compared [acty] 0.00448098803634
Tumors [neop] 0.00360429732769
Median [spco] 0.00265488999149
Increased [qnco] 0.00446973414713
HCC [neop] 0.00340112946253
topic9
Imaging, Magnetic Resonance [diap] 0.00272310404133
Tumour NOS [neop] 0.00395388328479
Important [qlco] 0.00279503249176
Groups [idcn] 0.00344147441949
Survival [acty] 0.00951805190435
Group [idcn] 0.00896622996576
resection [topp] 0.0051846120319
Based [ftcn] 0.00316548656513
Hepatic [blor] 0.00394263623037
Hepatectomy [topp] 0.00291565926078
Performed [ftcn] 0.00347230043043
Observed [ftcn] 0.00304979612849
Suggest [idcn] 0.00389114433063
Invasion [fndg] 0.00247424634094
Study [mnob] 0.00645110830673
Mortality [qnco] 0.00341145310967
Independent [idcn] 0.00272675766232
Conclusions [idcn] 0.00414823427155
Methods [inpr] 0.00595686910914
Compared [acty] 0.00521687646872
Cases [ftcn] 0.0059438006973
Criteria [inpr] 0.00264974557284
YEARS [tmco] 0.00506533681723
Human [humn] 0.00408454326071
TIME [tmco] 0.00282831633534
Cholangiocarcinoma [neop] 0.0030126367332
Liver Transplantation [topp] 0.00297699023248
YEAR [tmco] 0.00497274716005
LIVER [bpoc] 0.00634604975124
Related [qlco] 0.0032272216069
CCA [cgab] 0.00340104952538
Tumors [neop] 0.0028555667108
Identified [qlco] 0.003307658462
Progression [patf] 0.00414015779228
treatment [ftcn] 0.00460239109963
CIRRHOSIS [dsyn] 0.00477715296247
Liver Cancer [neop] 0.00308580951898
Risk Factors [qnco] 0.0110913121658
CANCER [neop] 0.00312407027035
Increased [qnco] 0.00359852367298
